Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze OVID stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate OVID investment potential.

What is OVID stock price today?

Get real-time OVID stock price, historical data, and price charts on Financhill. Track OVID performance with our advanced analysis tools.

Is OVID a good investment?

Evaluate OVID investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy OVID stock?

To buy OVID stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of OVID?

View detailed market capitalization data and company valuation metrics for OVID on our comprehensive analysis page.

What is the P/E ratio of OVID?

Use our fundamental analysis tools to view OVID P/E ratio and compare valuation metrics with industry peers.

What are OVID earnings?

View OVID earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Ovid Therapeutics, Inc. 10K Form

Sell

OVID
Ovid Therapeutics, Inc.

Last Price:

$1.63

Seasonality Move:

-8.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-03	10Q	OVID/Ovid Therapeutics, Inc. Quarterly
2023-08-04	10Q	OVID/Ovid Therapeutics, Inc. Quarterly
2023-05-05	10Q	OVID/Ovid Therapeutics, Inc. Quarterly
2022-11-08	10Q	OVID/Ovid Therapeutics, Inc. Quarterly
2022-08-09	10Q	OVID/Ovid Therapeutics, Inc. Quarterly
2022-05-10	10Q	OVID/Ovid Therapeutics, Inc. Quarterly

Receive OVID News And Ratings

See the #1 stock for the next 7 days that we like better than OVID

OVID Financial Statistics

Sales & Book Value

Annual Sales:	$566K
Cash Flow:	$-12.9M
Price / Cash Flow:	0
Annual Sales:	$0.63
Price / Book:	2.52

Profitability

EPS (TTM):	-0.51130
Net Income (TTM):	$-36.3M
Gross Margin:	$-34K
Return on Equity:	-59.7%
Return on Assets:	-43.48%

Ovid Therapeutics, Inc. Earnings Forecast

Key Ovid Therapeutics, Inc. Financial Ratios

The Gross Profit Margin over the past 4 years for OVID is -6.01%.
The Selling, General & Administrative Expenses for OVID have been equal to 4,537.81% of Gross Profit Margin.
The Research & Development expenses have been 6,425.27% of Revenue.
The Net Earning history of OVID is -4,670.14% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 6 years.

Ovid Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	OVID
CUSIP:	690469
Website:	ovidrx.com

Debt

Debt-to-Equity Ratio:	0.31
Current Ratio:	4.24
Quick Ratio:	3.77

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

OVID Technical Analysis vs Fundamental Analysis